Clinical Trial Update: The Effect of Effervescent Alendronate on Bone Turnover [Phase 4]

View source ↗

Summary

Phase 4 trial update on effervescent alendronate's effect on bone turnover in osteopenia or osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• Effervescent alendronate (alendronate)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Osteopenia or Osteoporosis | Phase 4 | Status: COMPLETED